IQity

1 day ago

ECP is one of the most studied and well understood glaucoma procedures.

Yet adoption remains limited.

Not because the evidence is lacking, but because technology has introduced practical barriers. Large capital consoles, complex OR setup, and limited flexibility in combined cataract glaucoma workflows all add friction to daily practice.

When visualization and energy delivery are tightly coupled to bulky platforms, precision can suffer, contributing to hesitation despite strong clinical outcomes.

If ECP is going to scale, technology must do more than exist.
It must simplify workflows, enhance control, and fit the reality of modern ophthalmic surgery.

#ECP #Ophthalmology #EyeCare #FutureOfOphthalmology #IQity

IQity

6 days ago

ECP works. Adoption does not.
Endoscopic cyclophotocoagulation is one of the most well studied procedures in glaucoma care, supported by strong long term clinical evidence, durable IOP reduction, and attractive reimbursement.

Yet ECP remains underutilized.
The reason is not a lack of data. In daily practice, surgeons face real barriers, including concerns around postoperative inflammation, large and expensive capital equipment, and workflow complexity in the OR.

A proven procedure should not be held back by practical limitations.

When evidence is clear, technology should make adoption easier, more efficient, and more scalable for real world practice. 

#Glaucoma #ECP #Ophthalmology #SurgicalInnovation #ClinicalEvidence #FutureOfEyeCare #IQity

Read the document here

IQity

Feb 3, 2026

Most people follow trends. A few pay attention to the signals behind them.

IQ-Signal is IQity’s curated perspective on the technologies, data, and shifts shaping eye care before they become obvious. It connects context, pattern recognition, and real world relevance to help make sense of what is coming next.

If you are building, investing in, or leading ophthalmology into the next decade, IQ-Signal belongs in your inbox.

https://lnkd.in/duqeX64F

#IQSignal #IQity #Ophthalmology #EyeCareInnovation

James Simms Sascha Burger Ehsan Sadri MD FACS Steve Wilmarth, MD

IQity

Jan 30, 2026

We are deeply grateful for the invaluable insight and guidance of our Board Member, Farrell “Toby” Tyson, pictured here operating with IQ-Flow. 

Dr. Tyson performed our first case of our handheld ECP devise in the US. His clinical perspective, real-world experience, and commitment to advancing ophthalmic care help ensure that what we build is not only innovative, but truly meaningful in the OR.

Thank you for shaping the future with us.

Tyson Eye 

#Ophthalmology #ClinicalLeadership #MedicalInnovation #SurgeonDriven #EyeCareInnovation #IQFlow

IQity

Jan 26, 2026

Most people follow trends. A few pay attention to signals.

IQ Signal is IQity’s curated perspective on the technologies and shifts shaping eye care before they become obvious. It is concise, thoughtful, and focused on what actually matters.

If you are building, investing in, or leading ophthalmology into the next decade, this is a conversation worth being part of.

Subscribe and stay ahead of what is coming next.

#IQSignal #Ophthalmology #MedicalInnovation #DigitalHealth #FutureOfHealthcare #EyeCare #IQity

IQity

Jan 22, 2026

CMS’ final 2026 Medicare fee schedule reinforces a long term shift in the economics of ophthalmic surgery.

Physician reimbursement continues to decline across procedures, with simple cataract surgery and vitrectomy seeing reductions of roughly 11 percent year over year. These changes are driven by adjustments to work RVUs and practice expense RVUs, particularly in ASC and hospital settings.

The macro reality is hard to ignore. Surgeons are being paid less per case, while procedural volume and clinical complexity continue to increase.

In this environment, efficiency, speed, and reliability in ophthalmic surgery are becoming increasingly critical. The systems, workflows, and technologies that support care delivery matter more than ever.

Source CMS Newsroom

#Ophthalmology #HealthcareEconomics #Medicare #ASC #SurgicalEfficiency #MedicalInnovation #IQity

Read the document here

IQity

Jan 20, 2026

January is Glaucoma Awareness Month.

Glaucoma continues to be one of the leading causes of irreversible blindness worldwide, often advancing quietly until vision loss becomes significant. That reality makes early diagnosis, thoughtful intervention, and efficient clinical workflows more important than ever.

At IQity, glaucoma is central to the problems we are working to solve. Across diagnostics and treatment, we are building technologies designed to support better outcomes while reducing complexity, saving clinician time, and lowering the overall cost of care.

Progress in glaucoma care is not about adding more tools.
It is about enabling smarter decisions, smoother workflows, and solutions that scale in real world practice.

This month is a reminder that meaningful change happens when insight, technology, and clinical reality are connected from start to finish.

#GlaucomaAwarenessMonth #GlaucomaCare #Ophthalmology #PatientSafety #MedicalInnovation #DigitalHealth #IQity

IQity

Jan 16, 2026

How effective is ECP when combined with phaco? The evidence is clear.

A recent study in the Pan-American Journal of Ophthalmology found that glaucoma patients undergoing phaco ECP experienced greater and more sustained IOP reduction compared with phaco alone, along with a reduced need for glaucoma medications.

ECP is one of the most well studied and well understood glaucoma procedures available. Yet for decades, high capital costs, fragile light fibers, and limited innovation have held it back from broader adoption.

We believe that needs to change.

With IQ Flow, we are rethinking how ECP is delivered, removing unnecessary barriers and bringing modern design to a proven approach in glaucoma care.

#IQFlow #Glaucoma #Ophthalmology #ECP #SurgicalInnovation #ClinicalEvidence #IOPReduction

Edward Hu Young Choi Sean Ianchulev MD MPH James Simms

Read the document here

IQity

Jan 14, 2026

We’ll be opening the first contingent of IQity demo slots for ASCRS 2026 shortly.

These hands-on sessions will give surgeons early access to the most mature versions yet of IQ-Flow, IQ-Meter and IQ-SurgiView and more – experienced as an integrated workflow.

Details and registration will follow soon. Watch this space!

IQity

Jan 9, 2026

More technology does not automatically mean better surgery.

In many operating rooms, it adds more steps, more interfaces, more complexity, and higher cost.

The real opportunity is simplification.
Designing systems that reduce friction, not add to it.

#Iqity #Simplification #Ophthalmology

James Simms Yousuf Khalifa Sascha Burger Steve Wilmarth, MD Daniel Chang